Total Payments
$7,901
2024 Payments
$57.30
Companies
13
Transactions
39
Medicare Patients
572
Medicare Billing
$62,664
Payment Breakdown by Category
Consulting$5,695 (72.1%)
Food & Beverage$1,557 (19.7%)
Travel$431.48 (5.5%)
Education$218.34 (2.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $5,695 | 2 | 72.1% |
| Food and Beverage | $1,557 | 29 | 19.7% |
| Travel and Lodging | $431.48 | 2 | 5.5% |
| Education | $218.34 | 6 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $6,504 | 17 | $0 (2021) |
| Boston Scientific Corporation | $354.27 | 5 | $0 (2022) |
| Covidien LP | $333.43 | 3 | $0 (2019) |
| PFIZER INC. | $125.00 | 1 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $124.74 | 1 | $0 (2023) |
| Allergan Inc. | $107.26 | 1 | $0 (2019) |
| Nestle HealthCare Nutrition Inc. | $80.79 | 1 | $0 (2021) |
| ABBVIE INC. | $80.55 | 1 | $0 (2022) |
| Janssen Biotech, Inc. | $70.70 | 2 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $44.72 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $57.30 | 4 | Takeda Pharmaceuticals U.S.A., Inc. ($28.32) |
| 2023 | $124.74 | 1 | E.R. Squibb & Sons, L.L.C. ($124.74) |
| 2022 | $295.94 | 3 | Boston Scientific Corporation ($215.39) |
| 2021 | $324.42 | 5 | Novo Nordisk Inc ($196.30) |
| 2020 | $206.14 | 3 | PFIZER INC. ($125.00) |
| 2019 | $6,290 | 9 | Novo Nordisk Inc ($5,741) |
| 2018 | $101.31 | 2 | Novo Nordisk Inc ($101.31) |
| 2017 | $501.93 | 12 | Novo Nordisk Inc ($465.82) |
All Payment Transactions
39 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/14/2024 | CONMED Corporation | CONMED BILIARY (Device), CONMED BIOPSY, CONMED POLYPECTOMY | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: GENERAL SURGERY | ||||||
| 10/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Immunology | ||||||
| 10/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/21/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $124.74 | General |
| Category: Cardiovascular | ||||||
| 10/13/2022 | Boston Scientific Corporation | Resolution 360 ULTRA Clip (Device) | Travel and Lodging | In-kind items and services | $176.49 | General |
| Category: Resolution 360_ENDO | ||||||
| 10/13/2022 | Boston Scientific Corporation | Resolution 360 ULTRA Clip (Device) | Food and Beverage | In-kind items and services | $38.90 | General |
| Category: Resolution 360_ENDO | ||||||
| 05/10/2022 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $80.55 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/24/2021 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $100.52 | General |
| Category: Obesity | ||||||
| 08/17/2021 | BOSTON SCIENTIFIC CORPORATION | RESOLUTION CLIP (Device) | Food and Beverage | In-kind items and services | $30.93 | General |
| Category: PAIN MANAGEMENT | ||||||
| 06/09/2021 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $80.79 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 06/01/2021 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $95.78 | General |
| Category: Obesity | ||||||
| 02/09/2021 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $16.40 | General |
| 12/22/2020 | Janssen Biotech, Inc. | STELARA (Biological) | Education | In-kind items and services | $56.99 | General |
| Category: Immunology | ||||||
| 02/03/2020 | Olympus America Inc. | Olympus EndoTherapy Accessories (Device), Olympus Biliary Devices, Olympus Respiratory Devices | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: EndoTherapy Products | ||||||
| 01/28/2020 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/15/2019 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $3,315.00 | General |
| 11/15/2019 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $46.00 | General |
| 09/26/2019 | Boston Scientific Corporation | CAPTIVATOR COLD (Device) | Food and Beverage | In-kind items and services | $87.55 | General |
| Category: POLYPECTOMY | ||||||
| 07/24/2019 | Covidien LP | — | Food and Beverage | In-kind items and services | $40.90 | General |
| 05/28/2019 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $2,380.00 | General |
| 05/09/2019 | Allergan Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $107.26 | General |
| Category: CYSTIC FIBROSIS | ||||||
| 03/28/2019 | Boston Scientific Corporation | RESOLUTION CLIP (Device) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: BILIARY DEVICES | ||||||
| 03/11/2019 | Covidien LP | — | Travel and Lodging | In-kind items and services | $254.99 | General |
| 03/11/2019 | Covidien LP | — | Food and Beverage | In-kind items and services | $37.54 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 107 | 130 | $107,124 | $11,557 |
| 2022 | 11 | 353 | 418 | $313,409 | $38,377 |
| 2021 | 5 | 112 | 118 | $107,901 | $12,730 |
Total Patients
572
Total Services
666
Medicare Billing
$62,664
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 24 | 24 | $48,072 | $4,038 | 8.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 34 | 56 | $12,406 | $3,385 | 27.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 21 | 22 | $9,908 | $2,233 | 22.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 28 | 28 | $36,738 | $1,901 | 5.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 41 | 41 | $82,123 | $8,122 | 9.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 71 | 71 | $82,709 | $5,580 | 6.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 34 | 55 | $15,763 | $5,174 | 32.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 32 | 36 | $14,010 | $3,819 | 27.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 39 | 65 | $13,012 | $3,661 | 28.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 26 | 26 | $11,564 | $3,228 | 27.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 23 | 34 | $8,866 | $2,729 | 30.8% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 31 | 32 | $9,670 | $2,544 | 26.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 31 | 31 | $42,944 | $1,919 | 4.5% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 14 | 16 | $16,648 | $1,318 | 7.9% |
| 45381 | Injection beneath lining of large bowel using a flexible endoscope | Facility | 2022 | 11 | 11 | $16,100 | $284.40 | 1.8% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 19 | 19 | $37,162 | $3,474 | 9.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 26 | 32 | $8,992 | $3,302 | 36.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 20 | 20 | $8,760 | $2,676 | 30.5% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 35 | 35 | $37,627 | $2,316 | 6.2% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 12 | 12 | $15,360 | $961.81 | 6.3% |
About Dr. Sagar Mehta, M.D
Dr. Sagar Mehta, M.D is a Internal Medicine healthcare provider based in Fort Myers, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/30/2008. The National Provider Identifier (NPI) number assigned to this provider is 1205002276.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sagar Mehta, M.D has received a total of $7,901 in payments from pharmaceutical and medical device companies, with $57.30 received in 2024. These payments were reported across 39 transactions from 13 companies. The most common payment nature is "Consulting Fee" ($5,695).
As a Medicare-enrolled provider, Mehta has provided services to 572 Medicare beneficiaries, totaling 666 services with total Medicare billing of $62,664. Data is available for 3 years (2021–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology, Gastroenterology
- Location Fort Myers, FL
- Active Since 04/30/2008
- Last Updated 11/14/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1205002276
Products in Payments
- Saxenda (Drug) $610.59
- Resolution 360 ULTRA Clip (Device) $215.39
- ZENPEP (Drug) $188.05
- XELJANZ (Drug) $125.00
- CAMZYOS (Drug) $124.74
- Wegovy (Drug) $100.52
- CAPTIVATOR COLD (Device) $87.55
- LINZESS (Drug) $80.55
- STELARA (Biological) $56.99
- RESOLUTION CLIP (Device) $51.33
- CONTRAVE (Drug) $36.11
- ENTYVIO (Biological) $28.32
- Olympus EndoTherapy Accessories (Device) $24.15
- CONMED BILIARY (Device) $15.27
- TREMFYA (Drug) $13.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Fort Myers
Dr. Michael Oleksyk, Md, MD
Internal Medicine — Payments: $570,596
Internal Medicine $570,596
Dr. Malissa Wood, Md, MD
Internal Medicine — Payments: $377,298
Internal Medicine $377,298
Oliver Abela, Md, MD
Internal Medicine — Payments: $70,958
Internal Medicine $70,958
Francisco De Jesus Paulino, Md, MD
Internal Medicine — Payments: $50,407
Internal Medicine $50,407
Dr. Vinayak Thakur, M.d, M.D
Internal Medicine — Payments: $19,038
Internal Medicine $19,038
Imtiaz Ahmad, Md, MD
Internal Medicine — Payments: $18,331
Internal Medicine $18,331